Primary Category:
Cancer Control and Prevention Protocols
Disease Category:
Bladder, Breast, Breast Metastatic, Cholangiocarcinoma, Colon, Colon Metastatic, Endometrial, Endometrial Metastatic, Esophageal, Gallbladder, Gastrointestinal, Genitourinary, Gynecologic, Head and Neck, Head and Neck Metastatic, Leukemia, Liver, Lung, Lymphoma, Melanoma, Metastatic Melanoma, Multiple Myeloma, Ovarian, Ovarian Metastatic, Pancreatic, Pancreatic Metastatic, Prostate, Prostate Metastatic, Rectal, Rectal Metastatic, Renal, Renal Metastatic, Sarcoma, Skin, Stomach, Thyroid
Status:
Open
Blinded Reference Set For Multicancer Early Detection Blood Tests
Eligible for screening study DCP 001
NCT#05334069
A212102 Thyroid, Melanoma, and Sarcoma cancer cohorts are closed to accrual effective November 15, 2023, with the release of Update 2.
A212102 is reopened to non-white male participants without a cancer diagnosis, effective August 1, 2023, with the implementation of Update 1.
A212102 is temporarily suspended to enrollment of participants without a cancer diagnosis. effective February 22, 2023.
A212102 will temporarily suspend enrollment to white female participants under (<) age 60 without a cancer diagnosis, effective December 1, 2022, at 4:30 PM EST.
